# Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure

> **NCT03576677** · PHASE4 · UNKNOWN · sponsor: **Finn Gustafsson** · enrollment: 42 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03576677
- **Lead sponsor:** Finn Gustafsson
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2019-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576677, "Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03576677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*